| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Mar 19, 2024 | Sale | $2.09 | 5,268 | 10,986 | 117,728 | Mar 21, 2024, 04:41 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Dec 20, 2023 | Sale | $1.38 | 4,077 | 5,629 | 97,996 | Dec 22, 2023, 04:11 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Sep 22, 2023 | Sale | $1.30 | 5,486 | 7,135 | 80,609 | Sep 22, 2023, 07:12 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Mar 16, 2023 | Sale | $1.98 | 2,037 | 4,031 | 71,095 | Mar 20, 2023, 06:43 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Jul 20, 2022 | Sale | $1.42 | 5,602 | 7,968 | 43,689 | Jul 21, 2022, 04:10 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | May 31, 2019 | Option Exercise | $8.21 | 1,812 | 14,878 | 11,791 | Jun 04, 2019, 04:08 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Mar 04, 2019 | Buy | $10.33 | 9,000 | 92,970 | 9,979 | Mar 05, 2019, 12:00 AM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Nov 30, 2018 | Option Exercise | $11.73 | 979 | 11,484 | 979 | Dec 06, 2018, 01:55 PM | |
| AMLN | AMYLIN PHARMACEUTICALS INC | ROWLAND LLOYD A | VP, Chief Compliance Officer | Aug 08, 2012 | Option Exercise | $31.00 | 7,974 | 247,194 | 1,360 | Aug 10, 2012, 06:39 PM | |
| AMLN | AMYLIN PHARMACEUTICALS INC | ROWLAND LLOYD A | VP, Chief Compliance Officer | Aug 08, 2012 | Option Exercise | $31.00 | 3,665 | 113,615 | 3,192 | Aug 10, 2012, 06:39 PM | |
| AMLN | AMYLIN PHARMACEUTICALS INC | ROWLAND LLOYD A | VP, Chief Compliance Officer | Aug 08, 2012 | Option Exercise | $31.00 | 35,426 | 1,098,206 | 35,014 | Aug 10, 2012, 06:39 PM | |
| AMLN | AMYLIN PHARMACEUTICALS INC | ROWLAND LLOYD A | VP, Chief Compliance Officer | Jul 25, 2012 | Option Exercise | $14.62 | 823 | 12,032 | 35,426 | Jul 26, 2012, 08:06 PM | |
| AMLN | AMYLIN PHARMACEUTICALS INC | ROWLAND LLOYD A | VP, Chief Compliance Officer | Mar 28, 2012 | Sale | $15.93 | 10,000 | 159,250 | 42,603 | Mar 29, 2012, 07:17 PM | |
| AMLN | AMYLIN PHARMACEUTICALS INC | ROWLAND LLOYD A | VP, Chief Compliance Officer | Mar 29, 2012 | Sale | $25.00 | 3,000 | 75,000 | 34,603 | Mar 29, 2012, 07:17 PM |
Menu